Peek behind the paper: evaluating the cost–effectiveness of population-based BRCA genetic testing

Written by Ranjit Manchanda

In this feature, we take a ‘peek behind the paper’ with Ranjit Manchanda (Queen Mary University of London, UK) to discuss recent research he was involved in investigating the cost–effectiveness of population-based genetic testing for common breast and ovarian cancer-linked mutations. Read the full research article, published in the journal Cancers, here >> Please could you introduce yourself? I am a Professor of Gynaecological Oncology at the Wolfson Institute of Preventive Medicine at Queen Mary University of London’s Barts Cancer Centre (London, UK) and a Consultant Gynaecological Oncologist at the Barts Health NHS Trust (London, UK). What prompted you to...

To view this content, please register now for access

It's completely free